• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向抗弓形虫疫苗:重组弓形虫ROP5和ROP18蛋白的免疫原性及保护活性评估

Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.

作者信息

Grzybowski Marcin M, Dziadek Bożena, Gatkowska Justyna M, Dzitko Katarzyna, Długońska Henryka

机构信息

Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland.

出版信息

Parasitol Res. 2015 Dec;114(12):4553-63. doi: 10.1007/s00436-015-4701-y. Epub 2015 Sep 4.

DOI:10.1007/s00436-015-4701-y
PMID:26337271
Abstract

Toxoplasmosis is one of the most common parasitic infections worldwide. An effective vaccine against human and animal toxoplasmosis is still needed to control this parasitosis. The polymorphic rhoptry proteins, ROP5 and ROP18, secreted by Toxoplasma gondii during the invasion of the host cell have been recently considered as promising vaccine antigens, as they appear to be the major determinants of T. gondii virulence in mice. The goal of this study was to evaluate their immunogenic and immunoprotective activity after their administration (separately or both recombinant proteins together) with the poly I:C as an adjuvant. Immunization of BALB/c and C3H/HeOuJ mice generated both cellular and humoral specific immune responses with some predominance of IgG1 antibodies. The spleen cells derived from vaccinated animals reacted to the parasite's native antigens. Furthermore, the immunization led to a partial protection against acute and chronic toxoplasmosis. These findings confirm the previous assumptions about ROP5 and ROP18 antigens as valuable components of a subunit vaccine against toxoplasmosis.

摘要

弓形虫病是全球最常见的寄生虫感染之一。仍需要一种有效的针对人类和动物弓形虫病的疫苗来控制这种寄生虫病。刚地弓形虫在侵入宿主细胞过程中分泌的多态性棒状体蛋白ROP5和ROP18,最近被认为是有前景的疫苗抗原,因为它们似乎是刚地弓形虫在小鼠中毒力的主要决定因素。本研究的目的是评估在将它们(单独或两种重组蛋白一起)与聚肌胞苷酸作为佐剂一起给药后它们的免疫原性和免疫保护活性。用其免疫BALB/c和C3H/HeOuJ小鼠产生了细胞和体液特异性免疫反应,其中IgG1抗体有一定优势。来自接种疫苗动物的脾细胞对寄生虫的天然抗原有反应。此外,免疫导致对急性和慢性弓形虫病有部分保护作用。这些发现证实了之前关于ROP5和ROP18抗原作为抗弓形虫病亚单位疫苗有价值成分的假设。

相似文献

1
Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.迈向抗弓形虫疫苗:重组弓形虫ROP5和ROP18蛋白的免疫原性及保护活性评估
Parasitol Res. 2015 Dec;114(12):4553-63. doi: 10.1007/s00436-015-4701-y. Epub 2015 Sep 4.
2
Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.经鼻腔途径增强 ROP18 疫苗对慢性弓形虫病的保护效力。
Med Microbiol Immunol. 2017 Feb;206(1):53-62. doi: 10.1007/s00430-016-0483-9. Epub 2016 Oct 18.
3
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.评价三种由弓形虫表面和分泌抗原组成的重组多抗原疫苗在实验性弓形虫病小鼠模型中的效果。
Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.
4
Toxoplasma gondii: cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens.
Exp Parasitol. 2015 Mar;150:1-6. doi: 10.1016/j.exppara.2015.01.006. Epub 2015 Jan 12.
5
The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.刚地弓形虫毒力相关的 rhoptry 蛋白 5(ROP5)是一种针对小鼠弓形虫病的新型疫苗候选物。
Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.
6
Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.刚地弓形虫:三种由重组 ROP2、ROP4、GRA4 和 SAG1 蛋白组成的三价抗原鸡尾酒对 BALB/c 小鼠慢性弓形虫病的疫苗潜力。
Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.
7
Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re.人参皂苷 Re 增强重组弓形虫 ROP18 抗原的保护性免疫应答
Exp Parasitol. 2013 Oct;135(2):234-9. doi: 10.1016/j.exppara.2013.07.013. Epub 2013 Jul 26.
8
Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii.针对刚地弓形虫的棒状体蛋白5和棒状体蛋白7 DNA疫苗诱导的免疫反应评估。
Parasite Immunol. 2016 Apr;38(4):209-17. doi: 10.1111/pim.12306.
9
Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection.表达刚地弓形虫棒状体蛋白18的病毒样颗粒比棒状体蛋白4能更好地诱导针对刚地弓形虫感染的保护作用。
Korean J Parasitol. 2018 Oct;56(5):429-435. doi: 10.3347/kjp.2018.56.5.429. Epub 2018 Oct 31.
10
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.刚地弓形虫:用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.

引用本文的文献

1
Design and immunological evaluation of a multi-epitope vaccine candidate against incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice.一种针对在BALB/c小鼠中整合MIC13、GRA1和SAG1抗原的多表位候选疫苗的设计与免疫学评估。
Food Waterborne Parasitol. 2025 Jun 2;40:e00269. doi: 10.1016/j.fawpar.2025.e00269. eCollection 2025 Sep.
2
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice.针对 CST1 抗原的异源免疫比 ROP18 更能在小鼠中提供更好的保护。
Nanomedicine (Lond). 2024;19(29):2437-2446. doi: 10.1080/17435889.2024.2403333. Epub 2024 Sep 25.
3
Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice.

本文引用的文献

1
Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.表达TgROP18的重组犬2型腺病毒(CAV-2-ROP18)对小鼠急性和慢性弓形虫感染的保护效力
BMC Infect Dis. 2015 Mar 4;15:114. doi: 10.1186/s12879-015-0815-1.
2
DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice.用编码弓形虫抗原 ROP5 和 GRA15 的基因进行 DNA 疫苗接种可诱导昆明小鼠对弓形虫病产生保护性免疫。
Expert Rev Vaccines. 2015 Apr;14(4):617-24. doi: 10.1586/14760584.2015.1011133.
3
弓形虫 MAG1 和 SAG1 双价 DNA 疫苗对 BALB/c 小鼠急性弓形虫病的保护效力。
Parasitol Res. 2023 Mar;122(3):739-747. doi: 10.1007/s00436-022-07745-8. Epub 2023 Jan 5.
4
Protective Effect Against Toxoplasmosis in Mice Vaccinated With Recombinant MIF, CDPK3, and 14-3-3 Protein Cocktail Vaccine.用重组MIF、CDPK3和14-3-3蛋白混合疫苗接种的小鼠对弓形虫病的保护作用
Front Immunol. 2021 Dec 22;12:755792. doi: 10.3389/fimmu.2021.755792. eCollection 2021.
5
Toxoplasmosis: Current and Emerging Parasite Druggable Targets.弓形虫病:当前及新出现的寄生虫可药物作用靶点
Microorganisms. 2021 Dec 7;9(12):2531. doi: 10.3390/microorganisms9122531.
6
Recombinant Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo.重组核糖体蛋白P2体外调节小鼠巨噬细胞功能并在体内提供抗急性弓形虫病免疫力。
Vaccines (Basel). 2021 Apr 7;9(4):357. doi: 10.3390/vaccines9040357.
7
Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice.细胞因子佐剂 IL-33 增强 ROP5 和 ROP18 鸡尾酒 DNA 疫苗对弓形虫感染的保护免疫作用。
Parasite. 2020;27:26. doi: 10.1051/parasite/2020021. Epub 2020 Apr 21.
8
Enzyme-Linked Aptamer Assay (ELAA) for Detection of ROP18 Protein in Human Serum.酶联适体分析(ELAA)检测人血清中的 ROP18 蛋白。
Front Cell Infect Microbiol. 2019 Nov 13;9:386. doi: 10.3389/fcimb.2019.00386. eCollection 2019.
9
The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice.嵌合蛋白的抗原组成对其抗小鼠慢性弓形虫病免疫保护活性的影响
Vaccines (Basel). 2019 Oct 18;7(4):154. doi: 10.3390/vaccines7040154.
10
Epitope-based vaccine as a universal vaccination strategy against infection: A mini-review.基于表位的疫苗作为预防感染的通用疫苗接种策略:一篇综述。
J Adv Vet Anim Res. 2019 Mar 24;6(2):174-182. doi: 10.5455/javar.2019.f329. eCollection 2019 Jun.
Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.
弓形虫二次感染期间的重复感染和毒力与确切的ROP5/ROP18等位基因组合相关。
mBio. 2015 Feb 24;6(2):e02280. doi: 10.1128/mBio.02280-14.
4
Toxoplasma gondii: cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens.
Exp Parasitol. 2015 Mar;150:1-6. doi: 10.1016/j.exppara.2015.01.006. Epub 2015 Jan 12.
5
The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases.弓形虫假激酶ROP5是免疫相关鸟苷三磷酸酶的变构抑制剂。
J Biol Chem. 2014 Oct 3;289(40):27849-58. doi: 10.1074/jbc.M114.567057. Epub 2014 Aug 12.
6
Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection.弓形虫感染期间γ干扰素反应中复杂的免疫细胞相互作用。
Infect Immun. 2014 Aug;82(8):3090-7. doi: 10.1128/IAI.01722-14. Epub 2014 May 27.
7
The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.弓形虫假激酶ROP5与ROP18和ROP17激酶形成复合物,协同控制小鼠的急性毒力。
Cell Host Microbe. 2014 May 14;15(5):537-50. doi: 10.1016/j.chom.2014.04.002.
8
Veterinary vaccines against toxoplasmosis.抗弓形虫病的兽用疫苗。
Parasitology. 2014 Sep;141(11):1365-78. doi: 10.1017/S0031182014000481. Epub 2014 May 7.
9
Vaccines against Toxoplasma gondii: new developments and perspectives.抗弓形虫疫苗:新进展与展望。
Expert Rev Vaccines. 2013 Nov;12(11):1287-99. doi: 10.1586/14760584.2013.844652. Epub 2013 Oct 4.
10
The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.刚地弓形虫毒力相关的 rhoptry 蛋白 5(ROP5)是一种针对小鼠弓形虫病的新型疫苗候选物。
Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.